Current evidence indicates that PFAS exposure is associated with increased blood lipid levels, as well as dysregulation of key transcription factors-such as peroxisome proliferator-activated receptors and sterol regulatory element-binding proteins-that can link PFAS exposure to tumor-promoting metabolic alterations. The gene discussed is CNBP; the disease is neoplasm.